相关实验视频

Updated: May 5, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 2, 2013

安卡费尔德与免疫疗法和化疗在膀癌中的疗法

Hilmi Sarı¹, Serdar Celik², Kutsal Yorukoglu³

¹Department of Urology, Etlik City Hospital, 06010 Ankara, Turkey.

Archivos espanoles de urologia

|March 3, 2026

概括

安卡弗德止血剂 (ABS) 在体外减少了膀癌细胞的存活率,与标准治疗相比. 组合疗法显示出显著的疗效,表明ABS作为个性化膀癌治疗的潜在辅助.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
药理学药理学是一个学科.

背景情况:

研究用于膀癌的新型抗瘤剂.
评估Ankaferd止血剂 (ABS) 与已建立的免疫疗法和化疗法.
专注于初级膀癌细胞培养.

研究的目的:

为了比较ABS与Bacillus Calmette-Guérin (BCG) 和gemcitabine (GCB) 的抗性作用.
评估涉及ABS,BCG和GCB的组合治疗的疗效.
分析非肌肉侵入性膀癌 (NMIBC) 细胞培养中的治疗反应.

主要方法:

从患者获得的膀瘤中建立的初级细胞培养 (PCC).
治疗组包括ABS,BCG,格姆西塔 (GCB) 和组合疗法 (ABS + BCG,ABS + GCB).
进行24小时细胞活力测试以量化治疗效果.

主要成果:

ABS,BCG和GCB显著降低了癌细胞活力 (p < 0.001).
组合治疗 (ABS + BCG,ABS + GCB) 进一步显著降低了细胞活力 (p < 0.001).
尽管类似的瘤阶段,组织学类型和等级,但观察到不同的细胞活力反应.

结论:

安卡费尔德止血剂 (ABS) 对膀癌细胞具有抗性质.
个性化治疗反应凸显了个性化治疗策略的必要性.
作为膀癌的辅助疗法,ABS显示出希望.

关键词:

安卡菲尔德的血液停止器.膀癌:膀癌是一种癌症.免疫疗法免疫疗法通过静脉内治疗治疗.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 31, 2013

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...